Deborah Froh headshot
DF

Deborah K. Froh

Professor
Unit: School of Medicine
Department: Department of Pediatrics
Office location and address
101 Hospital Dr
Charlottesville, Virginia 22903
Education
University of Chicago, 1982, MD
Residency, Pediatric Medicine, Albert Einstein College
Fellowships, Pediatric Pulmonology, University of California-San Francisco
A master protocol to test the impact of discontinuing chronic therapies in people with cystic fibrosis on highly effective CFTR modulator therapy (SIMPLIFY)
Source: Seattle Children's Research Institute
January 01, 2020 – December 31, 2023
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function in Infants and Young Children (BEGIN)
Source: Seattle Children's Research Institute
January 01, 2020 – December 31, 2022
MD-PEDT Cystic Fibrosis Fibrosing Colonopathy Observational Study
Source: Seattle Children's Research Institute
September 20, 2012 – September 20, 2022
CFF Center Grant FY 2021-2022
Source: Cystic Fibrosis Foundation
July 01, 2021 – June 30, 2022
Therapuetics Development Center - YR13 (2021-2022)
Source: Cystic Fibrosis Foundation
April 01, 2021 – March 31, 2022
CF Learning Network: Implementation Phase - Year 2
Source: Cincinnati Children's Hospital
January 01, 2021 – December 31, 2021
A prospective study to evaluate biological and clinical effects of significantly corrected CFTR function (the PROMISE Study)
Source: Seattle Children's Research Institute
November 01, 2018 – December 31, 2021
A Post-approval Observational Study to Evaluate the Long-term Effectiveness and Safety of Orkambi in US Patients Who completed Study VX12-809-105 Part A
Source: Vertex Pharmaceuticals Inc.
July 24, 2018 – July 23, 2021
CFF Center Grant FY 2020-2021
Source: Cystic Fibrosis Foundation
July 01, 2020 – June 30, 2021
Therapuetics Development Center - YR12
Source: Cystic Fibrosis Foundation
April 01, 2020 – March 31, 2021
CF Learning Network: Implementation Phase
Source: Cincinnati Children's Hospital
January 01, 2020 – December 31, 2020
MD-PEDT Implementation of Outpatient Clinical Pharmacy Services: Award for a Pharmacist and/or Pharmacy Technician
Source: Cystic Fibrosis Foundation
November 01, 2016 – October 31, 2020
A Phase 1/2 Study of VX-445 in Healthy Subjects and Subjects With Cystic Fibrosis
Source: Vertex Pharmaceuticals Inc.
September 25, 2017 – September 24, 2020
CFF Center Grant FY 2019-2020
Source: Cystic Fibrosis Foundation
July 01, 2019 – June 30, 2020
MD-PEDT CFF TDN ARC Award
Source: Cystic Fibrosis Foundation
January 01, 2015 – March 31, 2020
Therapuetics Development Center - YR11
Source: Cystic Fibrosis Foundation
January 01, 2019 – March 31, 2020
MD-PEDS Award for a Mental Health Coordinator
Source: Cystic Fibrosis Foundation
January 01, 2016 – December 31, 2019
CFF Center Grant FY 2018-2019
Source: Cystic Fibrosis Foundation
July 01, 2018 – June 30, 2019
MD-PEDT Parion Clearing Lungs with Enacinhibition in Cystic Fibrosis study P-1037 solution
Source: Parion Sciences, Inc.
April 24, 2015 – April 24, 2019
MD-PEDT EPIC Observational Study 002
Source: Seattle Children's Research Institute
September 01, 2013 – March 31, 2019
MD-PEDT-A Phase 3 Rollover Study to Evaluate the Safety and Efficacy of Long-Term Treatment with Lumacaftor in Combination with Ivacaftor
Source: Vertex Pharmaceuticals Inc.
March 10, 2016 – December 31, 2018
Therapuetics Development Center - YR10
Source: Cystic Fibrosis Foundation
January 01, 2018 – December 31, 2018
CFF Center Grant FY 2017-18
Source: Cystic Fibrosis Foundation
July 01, 2017 – June 30, 2018
MD-PEDT Vertex VX12-809-103
Source: Vertex Pharmaceuticals Inc.
June 13, 2013 – June 13, 2018
Therapuetics Development Center
Source: Cystic Fibrosis Foundation
January 01, 2017 – December 31, 2017
MD-PEDT An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger with Cystic Fibrosis
Source: Vertex Pharmaceuticals Inc.
August 27, 2013 – August 27, 2017
MD-PEDT Cystic Fibrosis Center grant
Source: Cystic Fibrosis Foundation
July 01, 2016 – June 30, 2017
MD-PEDT CFF THERAPEUTICS TDN YR8
Source: Cystic Fibrosis Foundation
January 01, 2016 – December 31, 2016
MD-PEDT Fundamentals: A Learning and Leadership Collaborative (Fun LLC)
Source: Cystic Fibrosis Foundation
June 01, 2015 – October 31, 2016
MD-PEDT Cystic Fibrosis Foundation Center Grant
Source: Cystic Fibrosis Foundation
July 01, 2015 – June 30, 2016
MD-PEDT UVA - CG Circle of Care
Source: Vertex Pharmaceuticals Inc.
January 05, 2015 – March 31, 2016
MD-PEDT Cystic Fibrosis Foundation Therapeutics TDN YR7
Source: Cystic Fibrosis Foundation
January 01, 2015 – December 31, 2015
Genetic Modifiers in Cystic Fibrosis Lung Disease
Source: University Of N.C. At Chapel Hill
January 01, 2002 – December 14, 2015
MD-PEDT CFF TDN Spring Meeting 2015
Source: Cystic Fibrosis Foundation
February 01, 2015 – July 31, 2015
MD-PEDT Cystic Fibrosis Foundation Center Grant
Source: Cystic Fibrosis Foundation
July 01, 2014 – June 30, 2015
MD-PEDT Froh CFF TDN Exp YR 6
Source: Cystic Fibrosis Foundation
January 01, 2014 – December 31, 2014
MD-PEDT Cystic Fibrosis Foundation Care Center
Source: Cystic Fibrosis Foundation
July 01, 2013 – June 30, 2014
MD-PEDT THe EPIC Observational Study - EPIC 002
Source: Seattle Children's Research Institute
April 01, 2009 – March 31, 2014
Therapeutics Development Center Expansion
Source: Cystic Fibrosis Foundation
January 01, 2009 – December 31, 2013
Mpex 209
Source: Mpex Pharmaceuticals, Inc.
July 22, 2011 – July 22, 2013
Cystic Fibrosis Foundation Center Grant
Source: Cystic Fibrosis Foundation
July 01, 2012 – June 30, 2013
Study to Evaluate the Efficacy and Safety of MP-376 in Stable Cystic Fibrosis Patients
Source: Mpex Pharmaceuticals, Inc.
May 18, 2011 – May 18, 2013
  • 2015-2018 Best Doctors in America® List